Raymond James & Associates GSK PLC Transaction History

Raymond James & Associates

1,141,789

Previous 1,165,772 2.06%

Previous $0 NaN%

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	N/A	-23,983 Reduced 2.06%	1,141,789 $0
Q2 2024 Jul 19, 2024	SELL	N/A	-22,192 Reduced 1.87%	1,165,772 $0
Q1 2024 Apr 22, 2024	BUY	N/A	62,899 Added 5.59%	1,187,964 $0
Q4 2023 Jan 16, 2024	SELL	N/A	-14,878 Reduced 1.31%	1,125,065 $0
Q3 2023 Oct 24, 2023	SELL	N/A	-7,989 Reduced 0.7%	1,139,943 $0
Q2 2023 Jul 25, 2023	BUY	N/A	21,053 Added 1.87%	1,147,932 $0
Q1 2023 Apr 14, 2023	BUY	N/A	78,647 Added 7.5%	1,126,879 $0
Q4 2022 Feb 08, 2023	SELL	N/A	-25,928 Reduced 2.41%	1,048,232 $0
Q3 2022 Oct 25, 2022	BUY	N/A	1,074,160 New	1,074,160 $31.6 Million

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.